DrugPatentWatch Database Preview
Sacituzumab govitecan - Biologic Drug Details
Email this page to a colleague
» See Plans and PricingSummary for sacituzumab govitecan
| Tradenames: | 1 |
| Patents: | 8 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for sacituzumab govitecan |
Recent Clinical Trials for sacituzumab govitecan
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Merck Sharp & Dohme Corp. | Phase 2 |
| Sara Tolaney | Phase 2 |
| Aditya Bardia | Phase 2 |
Patent Text Search: US Patents for sacituzumab govitecan
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | Immunomedics, Inc. (Morris Plains, NJ) | 2032-12-13 | RX | search | |
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | Immunomedics, Inc. (Morris Plains, NJ) | 2032-12-13 | RX | search | |
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | Immunomedics, Inc. (Morris Plains, NJ) | 2032-12-13 | RX | search | |
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | Immunomedics, Inc. (Morris Plains, NJ) | 2035-06-25 | RX | search | |
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | Immunomedics, Inc. (Morris Plains, NJ) | 2032-12-13 | RX | search | |
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA) | 2035-09-30 | RX | search | |
| Immunomedics Inc | TRODELVY | sacituzumab govitecan-hziy | INJECTABLE;INJECTION | 761115 | 001 | 2020-04-22 | Start Trial | The Regents of the University of California (Oakland, CA) | 2035-02-24 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for sacituzumab govitecan
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2010031032 | Start Trial |
| China | 1675245 | Start Trial |
| Denmark | 2396036 | Start Trial |
| Canada | 2607056 | Start Trial |
| Japan | 6366111 | Start Trial |
| Australia | 2007343600 | Start Trial |
| China | 107115526 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
